Skip to main content
. 2020 Sep 3;22(9):686–690. doi: 10.1089/dia.2019.0427

Table 1.

Demographic and Clinic Characteristics of Patients at Baseline

  Total Active Insulclock® Masked Insulclock P
Age, years 40.1 (13.9) 43.1 (13.8) 35.2 (13.8) 0.285
Sex, male, n (%) 9 (56.3) 5 (50.0) 4 (66.7) 0.515
Duration of diabetes, years 20.4 (11.9) 20.9 (12.5) 19.5 (11.9) 0.828
Weight, kg 69.4 (10.6) 65.2 (9.5) 75.1 (10.1) 0.085
BMI, kg/m2 24.8 (3.9) 23.2 (3.0) 27.0 (4.2) 0.070
Microvascular complications, n (%)
 Retinopathy 6 (37.5) 4 (40.0) 2 (33.3)  
 Nephropathy 2 (12.5) 2 (20.0) 0 (0)  
 Neuropathy 5 (31.3) 3 (30.0) 2 (33.3)  
SBP, mmHg 121.9 (18.4) 118.0 (8.3) 126.8 (27.5) 0.515
DBP, mmHg 75.0 (10.3) 72.4 (9.7) 78.3 (11.5) 0.434
Insulin dose, IU/kg
 Long-acting 0.39 (0.21) 0.31 (0.09) 0.50 (0.27)  
 Rapid-acting 0.41 (0.22) 0.34 (0.13) 0.50 (0.27)  

Data are expressed as mean (SD), except for sex and microvascular complications (%).

Statistical significance between groups was determined using either the Student's t-test or the chi-square test for continuous or categorical variables, respectively.

BMI, body mass index; BPM, beats per minute; DBP, diastolic blood pressure; IU, international units; SBP, systolic blood pressure; SD, standard deviation.